GISONDI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 14.897
EU - Europa 13.790
AS - Asia 10.116
SA - Sud America 1.644
Continente sconosciuto - Info sul continente non disponibili 445
AF - Africa 426
OC - Oceania 79
AN - Antartide 1
Totale 41.398
Nazione #
US - Stati Uniti d'America 14.560
RU - Federazione Russa 5.016
SG - Singapore 4.418
IT - Italia 2.848
CN - Cina 2.236
GB - Regno Unito 2.089
BR - Brasile 1.327
HK - Hong Kong 949
VN - Vietnam 885
DE - Germania 672
IE - Irlanda 654
FR - Francia 642
SE - Svezia 568
FI - Finlandia 506
KR - Corea 336
BD - Bangladesh 300
IN - India 198
CA - Canada 158
NL - Olanda 144
UA - Ucraina 143
TR - Turchia 139
ID - Indonesia 135
ES - Italia 133
AR - Argentina 103
JP - Giappone 97
MX - Messico 95
NG - Nigeria 77
IQ - Iraq 76
TG - Togo 72
PL - Polonia 70
ZA - Sudafrica 69
AU - Australia 67
EC - Ecuador 60
AT - Austria 57
BJ - Benin 57
CH - Svizzera 39
PK - Pakistan 39
SA - Arabia Saudita 37
BE - Belgio 35
CO - Colombia 33
MY - Malesia 33
UZ - Uzbekistan 31
CL - Cile 30
MA - Marocco 30
EG - Egitto 27
IR - Iran 27
PY - Paraguay 25
KE - Kenya 21
PH - Filippine 21
JM - Giamaica 20
VE - Venezuela 20
TN - Tunisia 19
BO - Bolivia 18
DZ - Algeria 18
KZ - Kazakistan 17
CZ - Repubblica Ceca 16
AL - Albania 15
IL - Israele 15
NP - Nepal 15
DK - Danimarca 14
HU - Ungheria 14
PE - Perù 14
PT - Portogallo 14
RO - Romania 14
HR - Croazia 13
JO - Giordania 12
UY - Uruguay 12
AZ - Azerbaigian 11
TH - Thailandia 11
GR - Grecia 10
LT - Lituania 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
CR - Costa Rica 9
DO - Repubblica Dominicana 9
ET - Etiopia 9
AE - Emirati Arabi Uniti 8
MM - Myanmar 8
TW - Taiwan 8
BY - Bielorussia 7
GE - Georgia 6
GH - Ghana 6
HN - Honduras 6
IS - Islanda 6
LK - Sri Lanka 6
OM - Oman 6
AO - Angola 5
EE - Estonia 5
GD - Grenada 5
LV - Lettonia 5
BH - Bahrain 4
BN - Brunei Darussalam 4
GT - Guatemala 4
KW - Kuwait 4
LB - Libano 4
NI - Nicaragua 4
NO - Norvegia 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
AM - Armenia 3
Totale 40.878
Città #
Singapore 2.263
Ashburn 1.893
Southend 1.591
Moscow 1.570
San Jose 1.519
Dallas 1.348
Chandler 1.055
Jacksonville 960
Hong Kong 928
Council Bluffs 784
Dublin 643
Woodbridge 553
Verona 550
Houston 446
Ann Arbor 431
The Dalles 407
Beijing 385
Ho Chi Minh City 323
New York 298
Los Angeles 256
Milan 251
Wilmington 220
Lawrence 215
Princeton 215
Hanoi 202
Rome 183
Helsinki 159
Munich 150
Santa Clara 145
Buffalo 140
Jinan 135
Nanjing 133
Redondo Beach 130
São Paulo 121
London 115
Shenyang 100
Sindelfingen 93
Jakarta 80
Chicago 79
Tianjin 73
Lomé 72
Abuja 68
Frankfurt am Main 67
Bologna 65
Hebei 63
Lappeenranta 62
Tokyo 62
Atlanta 59
Guangzhou 58
Cotonou 57
Seattle 57
Naples 56
Haikou 55
Phoenix 55
Orem 54
Washington 54
Changsha 53
Warsaw 51
Amsterdam 47
Chennai 47
Columbus 46
Hangzhou 45
Madrid 44
Nanchang 44
Brooklyn 43
Redwood City 42
Toronto 42
Rio de Janeiro 41
Montreal 40
Haiphong 39
Da Nang 38
Zhengzhou 38
Boardman 37
Johannesburg 37
Belo Horizonte 36
Turin 36
Jiaxing 34
Mexico City 34
Vienna 33
Brasília 32
Florence 32
Nuremberg 32
Shanghai 32
Venice 30
Brussels 29
Falls Church 29
Kent 29
Kuala Lumpur 29
Curitiba 28
Manchester 28
Ningbo 28
San Francisco 28
Stockholm 28
Boston 27
Denver 27
Genoa 27
Redmond 27
Tashkent 27
Istanbul 26
Esslingen am Neckar 25
Totale 23.653
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 680
Heat urticaria: a revision of published cases with an update on classification and management 509
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 453
Il ruolo della vitamina D nella dermatite atopica 443
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 366
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 365
A systematic review of treatments for pityriasis lichenoides 343
A new instrument for the screening of psoriatic arthritis among psoriatic patients 337
Dietary supplements for lipedema 320
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 213
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 203
Advanced Glycation End Products in the Pathogenesis of Psoriasis 203
Gender perspective in the management of psoriasis 194
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 190
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 185
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 184
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 180
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 176
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 176
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 174
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 172
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer 172
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 171
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 171
Polymorphisms, diet and nutrigenomics 169
Lebbra lepromatosa. 168
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 168
Acneiform eruption induced by cetuximab 167
Retention rate of systemic drugs in patients with chronic plaque psoriasis 167
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 165
Main nutritional deficiencies 164
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 164
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 163
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 163
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 162
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 162
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 161
Impact of the COVID-19 pandemic on melanoma diagnosis 160
Incidence of respiratory and allergic symptoms in Italian and immigrant children 159
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 159
Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series. 159
Psoriasis, the liver, and the gastrointestinal tract 158
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 158
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 157
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 155
Psoriasis and the metabolic syndrome 155
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 153
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 152
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 152
Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review 152
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 151
Impact of TNF-α antagonists on the quality of life in selected skin diseases 151
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 151
Complicanze dell'obesità: la cute 150
Squamous cell carcinoma arising in lupus vulgaris. 149
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 149
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 149
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 149
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 148
Targeting TNF-a in psoriasis and psoriatic arthritis. 147
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 147
Aggiornamento sulla terapie biologiche della psoriasi 146
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 146
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 146
Attitude to treatment of patients with psoriasis attending SPA center 144
Effects of secukinumab on serum adipocytokines: preliminary data 144
Image Gallery: Pyoderma gangrenosum of the penis. 144
Pimecrolimus in dermatology: atopic dermatitis and beyond. 143
Vitamin D levels in patients with psoriasis with or without arthritis 143
Ki67/MART1 and p63/SOX10 Dual Immunohistochemistry Allows a Correct Interpretation of the Melanocytic Component in the Diagnosis of Pigmented Pilomatricoma 143
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 142
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 142
Severe impairment of quality of life in Hailey-Hailey disease. 140
Chronic plaque psoriasis is associated with increased arterial stiffness 140
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 140
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 140
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 139
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 139
Systemic therapy of psoriasis in diabetic patients 138
Phenotypes of atopic dermatitis 137
Vitamin D status in patients with chronic plaque psoriasis 137
The metabolic syndrome in psoriasis 137
Considerations for Systemic Treatment of Psoriasis in Obese Patients 137
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study 136
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 136
Advanced Glycation End Products and Psoriasis 135
Dermatite atopica. 135
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 134
Psoriasi. Una guida per una migliore gestione del paziente. 134
Metabolic comorbidities and psoriasis. 134
Some considerations about the importance of alliance between patients and dermatologists in psoriasis 134
Diabetes and the Skin 134
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 133
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 132
The expectations of patients with psoriasis during an office consultation 132
Dermoscopic features of nevoid melanoma: a retrospective study 131
Uncommon Non‑Infectious Annular Dermatoses 131
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 131
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 131
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 131
Totale 17.764
Categoria #
all - tutte 152.190
article - articoli 147.701
book - libri 444
conference - conferenze 0
curatela - curatele 0
other - altro 255
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.790
Totale 304.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.353 0 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20256.581 386 349 230 1.037 360 299 414 308 941 466 582 1.209
2025/202618.788 1.418 925 1.662 2.672 4.371 1.123 1.780 1.209 1.392 993 537 706
2026/20271.552 853 699 0 0 0 0 0 0 0 0 0 0
Totale 41.398